Immunotherapy in Cancer: Biology Therapy

  • Monika D. Khichade Student, Shivlingeshwar College of Pharmacy Almala , Latur , (M.S) India.
  • Dr .Sameer Shafi Head of Department (Pharmaceutics) Shivlingeshwar College of Pharmacy, Almala ,Tq. Ausa, Dist .Latur (M.S) India
  • Priyanka S. Nilangekar Student, Shivlingeshwar College of Pharmacy Almala , Latur , (M.S) India.
  • Aishwarya S. Gandhle Student, NIPER Hydrabad, India.
  • Mohini A . Gurav Student, Shivlingeshwar College of Pharmacy Almala , Latur , (M.S) India
  • Vishal B. Phulsundar Student, Shivlingeshwar College of Pharmacy Almala , Latur , (M.S) India.
DOI: https://doi.org/10.32553/jbpr.v11i5.937
Keywords: cancer, immunotherapy, checkpoint inhibitor, nanomedicine

Abstract

Abstract:

The relationship between immune system and cancer has progressively increased in the last few years. Recent advancement in treating cancer immunotherapy includes monoclonal antibodies, adaptive cancer therapy; monoclonal antibodies have came into force. General therapies include surgery, radiation and chemotherapy etc... Beyond that the immunotherapy in treating cancer helps our immune system to fight against tumor forming cell, which acts as an example of precision medicine .It mainly targets tumor in filtering lymphocytes, CAR Tcells, TCR Tcell etc…. Personalized combination therapy stands as promising stratergy for upcoming cancer treatment, personalized medicines includes patient derived tumor cell DNA oncolytic viruses dendritic cells etc.

Published
2022-11-14
How to Cite
Khichade, M. D., Shafi, D. .Sameer, S. Nilangekar, P., S. Gandhle, A., A . Gurav, M., & B. Phulsundar, V. (2022). Immunotherapy in Cancer: Biology Therapy. Journal of Biomedical and Pharmaceutical Research, 11(5), 62-73. https://doi.org/10.32553/jbpr.v11i5.937
Issue
Vol. 11 No. 5 (2022)
Section
Articles

Copyright (c) 2022 Journal of Biomedical and Pharmaceutical Research

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Creative Commons LicenseJournal of Biomedical and Pharmaceutical Research by Articles is licensed under a Creative Commons Attribution 4.0 International License.